2025 From Bainbridge to bedside: applying automation insights to medical curriculum and assignment design in the artificial intelligence era. Ahn S Korean J Med Educ
2025 Barriers and opportunities in biobank utilization: insights from a 3-year repeated cross-sectional survey of the Female Breast and Genital Disease with Microbiome Biobank Network in South Korea. Ahn S, Cho HJ, Kang MS, Seo AN, Kim L, Choi KU, Roh MS, Kim EY J Yeungnam Med Sci
2025 Public Perceptions and Barriers to Tuberculosis Treatment in Korea: A Large Language Model-Based Analysis of Naver Knowledge-iN Data from 2002 to 2024. Park H, Kim S, Kim G, Chang S, Shin JG, Ahn S Healthc Inform Res
2025 Large Language Model Advances in Transfusion Medicine: From Answering Questions to Supporting Clinical Decisions. Ahn S Ann Lab Med
2025 A guide to evade hallucinations and maintain reliability when using large language models for medical research: a narrative review. Ahn S Ann Pediatr Endocrinol Metab
2025 Large language model usage guidelines in Korean medical journals: a survey using human-artificial intelligence collaboration. Ahn S J Yeungnam Med Sci
2024 Drug-Drug Interactions between COVID-19 and Tuberculosis Medications: A Comprehensive Review of CYP450 and Transporter-Mediated Effects. Jony MR, Ahn S Pharmaceuticals (Basel)
2024 The transformative impact of large language models on medical writing and publishing: current applications, challenges and future directions. Ahn S Korean J Physiol Pharmacol
2024 Data science through natural language with ChatGPT's Code Interpreter. Ahn S Transl Clin Pharmacol
2024 Population pharmacokinetic model of rifampicin for personalized tuberculosis pharmacotherapy: Effects of SLCO1B1 polymorphisms on drug exposure. Hoa PQ, Kim HK, Jang TW, Seo H, Oh JY, Kim HC, Shin AY, Min J, Jayanti RP, Hung TM, Anh NK, Ahn S, Long NP, Cho YS, Shin JG, cPMTb Int J Antimicrob Agents
2023 Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers. Phat NK, Tien NTN, Anh NK, Yen NTH, Lee YA, Trinh HKT, Le KM, Ahn S, Cho YS, Park S, Kim DH, Long NP, Shin JG Front Immunol
2023 Transforming clinical trials: the emerging roles of large language models. Ghim JL, Ahn S Transl Clin Pharmacol
2023 Development of a population pharmacokinetic model of pyrazinamide to guide personalized therapy: impacts of geriatric and diabetes mellitus on clearance. Kim R, Jayanti RP, Lee H, Kim HK, Kang J, Park IN, Kim J, Oh JY, Kim HW, Lee H, Ghim JL, Ahn S, Long NP, Cho YS, Shin JG Front Pharmacol
2023 Recommendation of pharmacokinetics/pharmacodynamics target of ethambutol to suppress tuberculosis resistance: A population pharmacokinetics study on a large prospective cohort. Hung TM, Jayanti RP, Lee HY, Kim HJ, Mok J, Jang TW, Oh JY, Kim JS, Ko Y, Min J, Hoa PQ, Ahn S, Long NP, Cho YS, Shin JG, cPMTb Int J Antimicrob Agents
2023 Impact of Criterion Versus Norm-Referenced Assessment on the Quality of Life in Korean Medical Students. Park CH, Kwon J, Lee JT, Ahn S J Korean Med Sci
2023 CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor. Cho HY, Ahn S, Cho YS, Seo SK, Kim DH, Shin JG, Lee SJ Pharmaceuticals (Basel)
2023 Multimodal plasma metabolomics and lipidomics in elucidating metabolic perturbations in tuberculosis patients with concurrent type 2 diabetes. Yen NTH, Anh NK, Jayanti RP, Phat NK, Vu DH, Ghim JL, Ahn S, Shin JG, Oh JY, Long NP, Kim DH Biochimie
2023 Development of population pharmacokinetics model and Bayesian estimation of rifampicin exposure in Indonesian patients with tuberculosis. Soedarsono S, Jayanti RP, Mertaniasih NM, Kusmiati T, Permatasari A, Indrawanto DW, Charisma AN, Lius EE, Yuliwulandari R, Quang Hoa P, Ky Phat N, Thu VTA, Ky Anh N, Ahn S, Phuoc Long N, Cho YS, Shin JG Tuberculosis (Edinb)
2023 Tumor Microenvironment and Genes Affecting the Prognosis of Temozolomide-Treated Glioblastoma. Jang Y, Cheong W, Park G, Kim Y, Ha J, Ahn S J Pers Med
2022 Building and analyzing machine learning-based warfarin dose prediction models using scikit-learn. Ahn S Transl Clin Pharmacol
2022 Center for Personalized Precision Medicine for Tuberculosis: Smart Research and Development Workstation. Nguyen VL, Ahn S, Hoa PQ, Long NP, Ahn S, Cho YS, Shin JG Healthc Inform Res
2021 Comparison of multivariate linear regression and a machine learning algorithm developed for prediction of precision warfarin dosing in a Korean population. Nguyen VL, Nguyen HD, Cho YS, Kim HS, Han IY, Kim DK, Ahn S, Shin JG J Thromb Haemost
2019 A new population pharmacokinetic model for vancomycin in patients with variable renal function: Therapeutic drug monitoring based on extended covariate model using CKD-EPI estimation. Kim DJ, Lee DH, Ahn S, Jung J, Kiem S, Kim SW, Shin JG J Clin Pharm Ther
2019 Pharmacokinetics of fixed-dose combination of atorvastatin and metformin compared with individual tablets. Ghim JL, Phuong NTT, Kim MJ, Kim EJ, Song GS, Ahn S, Shin JG, Kim EY Drug Des Devel Ther
2019 Pharmacokinetic comparison of a fixed-dose combination versus concomitant administration of amlodipine, olmesartan, and rosuvastatin in healthy adult subjects. Oh M, Shin JG, Ahn S, Kim BH, Kim JY, Shin HJ, Shin HJ, Ghim JL Drug Des Devel Ther
2019 Physiologically Based Pharmacokinetic Modeling Approach to Predict Drug-Drug Interactions With Ethionamide Involving Impact of Genetic Polymorphism on FMO3. Nguyen PTT, Parvez MM, Kim MJ, Yoo SE, Ahn S, Ghim JL, Shin JG J Clin Pharmacol
2018 Survey on the undergraduate curriculum in clinical pharmacology and interns' prescribing ability in South Korea. Gu N, Kim KJ, Lim CY, Lee JK, Rhee MY, Shin KH, Lee SH, Ahn S Transl Clin Pharmacol
2018 Development of a Physiologically Based Pharmacokinetic Model of Ethionamide in the Pediatric Population by Integrating Flavin-Containing Monooxygenase 3 Maturational Changes Over Time. Nguyen PTT, Parvez MM, Kim MJ, Ho Lee J, Ahn S, Ghim JL, Shin JG J Clin Pharmacol
2018 Transient Anosmia Induces Depressive-like and Anxiolytic-like Behavior and Reduces Amygdalar Corticotropin-Releasing Hormone in a ZnSO4-Induced Mouse Model. Ahn S, Choi M, Kim H, Yang EJ, Mahmood U, Kang SI, Shin HW, Kim DW, Kim HS Chem Senses
2018 Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder. Mahmood U, Ahn S, Yang EJ, Choi M, Kim H, Regan P, Cho K, Kim HS Pharmacol Res
2016 Hippocampus-based contextual memory alters the morphological characteristics of astrocytes in the dentate gyrus. Choi M, Ahn S, Yang EJ, Kim H, Chong YH, Kim HS Mol Brain
2016 Correction: Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice. Yang EJ, Ahn S, Lee K, Mahmood U, Kim HS PLoS One
2016 Early Behavioral Abnormalities and Perinatal Alterations of PTEN/AKT Pathway in Valproic Acid Autism Model Mice. Yang EJ, Ahn S, Lee K, Mahmood U, Kim HS PLoS One
2016 Chronic anosmia induces depressive behavior and reduced anxiety via dysregulation of glucocorticoid receptor and corticotropin-releasing hormone in a mouse model. Ahn S, Shin HW, Mahmood U, Khalmuratova R, Jeon SY, Jin HR, Choi JS, Kim HS, Kim DW Rhinology
2015 Phloroglucinol Attenuates the Cognitive Deficits of the 5XFAD Mouse Model of Alzheimer's Disease. Yang EJ, Ahn S, Ryu J, Choi MS, Choi S, Chong YH, Hyun JW, Chang MJ, Kim HS PLoS One
2014 Dehydroevodiamine·HCl Improves Stress-Induced Memory Impairments and Depression Like Behavior in Rats. Kim HJ, Shin KY, Chang KA, Ahn S, Choi HS, Kim HS, Suh YH Korean J Physiol Pharmacol
2014 In vivo imaging of human adipose-derived stem cells in Alzheimer's disease animal model. Ha S, Ahn S, Kim S, Joo Y, Chong YH, Suh YH, Chang KA J Biomed Opt
